| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |